TMC435350-TiDP16-C202: A Study to Assess the Activity of TMC435 on Hepatitis C Virus in Patients Who Have Never Received Treatment for Their Hepatitis C Infection.

This study is ongoing, but not recruiting participants.

Study NCT00812331 Information provided by Tibotec Pharmaceuticals, Ireland

First Received: December 18, 2008 Last Updated: October 29, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	November 2009
Estimated Primary Completion Date:	November 2009 (Final data collection date for primary outcome measure)